Oculomotor Function in Frontotemporal Lobar Degeneration, Related Disorders and Alzheimer's Disease
Overview
Authors
Affiliations
Frontotemporal lobar degeneration (FTLD) often overlaps clinically with corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP), both of which have prominent eye movement abnormalities. To investigate the ability of oculomotor performance to differentiate between FTLD, Alzheimer's disease, CBS and PSP, saccades and smooth pursuit were measured in three FTLD subtypes, including 24 individuals with frontotemporal dementia (FTD), 19 with semantic dementia (SD) and six with progressive non-fluent aphasia (PA), as compared to 28 individuals with Alzheimer's disease, 15 with CBS, 10 with PSP and 27 control subjects. Different combinations of oculomotor abnormalities were identified in all clinical syndromes except for SD, which had oculomotor performance that was indistinguishable from age-matched controls. Only PSP patients displayed abnormalities in saccade velocity, whereas abnormalities in saccade gain were observed in PSP > CBS > Alzheimer's disease subjects. All patient groups except those with SD were impaired on the anti-saccade task, however only the FTLD subjects and not Alzheimer's disease, CBS or PSP groups, were able to spontaneously self-correct anti-saccade errors as well as controls. Receiver operating characteristic statistics demonstrated that oculomotor findings were superior to neuropsychological tests in differentiating PSP from other disorders, and comparable to neuropsychological tests in differentiating the other patient groups. These data suggest that oculomotor assessment may aid in the diagnosis of FTLD and related disorders.
The link between eye movements and cognitive function in mild to moderate Alzheimer's disease.
Ma X, Yao L, Liu S, Weng X, Bao R, Yang Y Exp Brain Res. 2025; 243(1):39.
PMID: 39754620 DOI: 10.1007/s00221-024-06957-x.
Qi J, Lian T, Guo P, He M, Li J, Li J Front Aging Neurosci. 2024; 16:1471698.
PMID: 39640423 PMC: 11617582. DOI: 10.3389/fnagi.2024.1471698.
Advancements in eye movement measurement technologies for assessing neurodegenerative diseases.
Band T, Bar-Or R, Ben-Ami E Front Digit Health. 2024; 6:1423790.
PMID: 39027628 PMC: 11254822. DOI: 10.3389/fdgth.2024.1423790.
Aging impairs reactive attentional control but not proactive distractor inhibition.
Kim A, Senior J, Chu S, Mather M J Exp Psychol Gen. 2024; 153(7):1938-1959.
PMID: 38780565 PMC: 11250690. DOI: 10.1037/xge0001602.
Kim A, Nguyen K, Mather M bioRxiv. 2024; .
PMID: 38766110 PMC: 11100628. DOI: 10.1101/2024.05.06.592619.